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illusTraTive case 
your patient is an 83-year-old woman who 
fell at home. radiographs show a distal 
radial fracture, which is treated with cast-
ing. you know that a quarter of patients 
with wrist fractures will suffer from com-
plex regional pain syndrome, and there 
is no well-established treatment for it. Is 
there any way to reduce this woman’s 
chance of getting this painful syndrome?
background
z		Often	misdiagnosed
We were surprised to learn how common-
ly patients suffer from complex regional 
pain syndrome (CRPS) after a fracture. 
We think this diagnosis is frequently 
missed or misdiagnosed. Even with reso-
lution, however, symptoms can be both-
ersome—and in 1% to 2% of cases, quite 
severe. 
CRPS, a syndrome of pain and 
autonomic dysfunction after trauma, is 
divided into 2 types:
•  type I has no obvious damage to 
nerves 
•  type II is due to definite damage to 
nerves (causalgia). 
The etiology of CRPS (all further 
references here will be to type I) is still 
unclear, but not for lack of proposed 
theories. Sigmund Freud suggested that it 
has an origin in personality; there is little 
evidence to support his theory.2 
Other theories include microtrauma 
to nerves, sympathetic nervous system 
abnormalities (hence the former name, 
reflex sympathetic dystrophy), abnor-
malities of the inflammatory response, 
and physiologic responses to immobili-
zation. It is often described as a biphasic 
syndrome, with early edema followed 
by contracture and stiffness. It typically 
affects the extremities.2 
crPs more likely in women. A popu-
lation-based study in Olmsted Coun-
ty, MN found an incidence of 5.5 per 
100,000 person-years, with a prevalence 
of 20.6 per 100,000. Women were af-
fected 4 times more than men.3 Fracture 
(46%) and sprain (12%) were the lead-
ing triggers, followed by other injuries, 
including crush, stroke, and contusion.
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vitamin C 500 mg daily for 
50 days reduced the risk 
of complex regional pain 
syndrome for patients 
with a wrist fracture.
We think vitamin C 500 
mg a day for 7 weeks is well 
worth recommending.1
Strength of recommendation 
a: based on 2 consistent, well-designed randomized 
controlled trials (rCTs)
Zollinger Pe, Tuinebreijer We, breederveld 
rS, Kreis rW. Can vitamin C prevent complex 
regional pain syndrome in patients with wrist 
fractures? a randomized, controlled, multicenter 
dose-response study. J Bone Joint Surg Am 
2007; 89:1424–1431.1
Practice changer 
PURLs methodology
This study was selected and 
evaluated using FPIN’s Priority 
Updates from the Research 
Literature (PURL) Surveillance 
System methodology. The 
criteria and findings leading to 
the selection of this study as 
a PURL can be accessed at 
www.jfponline.com/purls. 
New feature
Vitamin C 500 mg/d 
for 7 weeks  
is worth  
recommending  
to prevent  
complex regional 
pain syndrome 
after fracture
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Vitamin C to prevent pain after fracture
Over	half	of	patients	may	suffer
Despite typically reported rates of 1% to 
2% for severe, chronic CRPS following 
these injuries, it appears that milder cases 
are substantially more common. 
In a cohort of 274 patients with 
Colles’s fractures, at 2 weeks, 24% met all 
4 of the criteria used in the study to 
define CRPS, specifically: 
• tenderness
• vascular instability 
• stiffness
•  objective swelling of areas distal to 
and distinctive from the fracture. 
Although 48% met none of the crite-
ria, the remaining 28% had at least some 
of the criteria.4 
most patients recover. Patients with 
partial CRPS improved more rapidly 
than those with CRPS; by 5 months, 
most had recovered completely. Patients 
with definitive CRPS also improved, al-
though about 65% still reported stiffness 
in hands and wrists at 5 months. Another 
cohort study of 100 patients, also with 
Colles’s fractures, found similar rates of 
CRPS 9 weeks.5
clinical conTexT
z		Treatments	are	not		
very	effective
A systematic review of therapeutic options 
found 18 randomized controlled studies 
evaluating possible therapies for CRPS.6 
The overall quality of data was low. The 
authors concluded there was little to no 
evidence for sympathetic blockade (either 
via stellate ganglion block or RIS block), 
radical scavenging with DMSO, pred-
nisolone, acupuncture, or manual lymph 
drainage. Bisphosphonates and calcitonin, 
as well as qigong exercises, did show some 
potential, but data were too limited to 
draw a firm conclusion. 
guidelines recommend early interven-
tion with physical and psychological ther-
apy, as well as adequate pain control.7 
The systematic review also identi-
fied 2 studies of preventive interventions. 
A pilot study of vitamin C (by the au-
thors of the trial that is the subject of this 
PURL) showed some efficacy.8 An RCT 
of IV guanethidine found no benefit 
compared with saline.6 
sTudy summary
z		Vitamin	C	reduced		
the	rate	of	CRPS
This randomized, multicenter, dose-
ranging, placebo-controlled trial was 
performed at 3 hospitals in the Nether-
lands.1 Any adult (>18 years of age) with 
a fracture of one or both wrists treated 
in the emergency departments of these 
hospitals was invited to participate. Dur-
ing 2001–2004, there were 2137 pa-
tients with wrist fractures. Of these, 416 
(19.5%) patients (with 427 fractures) 
“Granted, pain can 
be mild, but it can 
go on for months”
apparently quite a few patients with complex 
regional pain syndrome (CrPS) saw me during 
my 20 years of practice, but I did not see them, 
or at least I did not recognize their symptoms.
as many as 50% of cast complaints—or 
post-cast complaints—probably represented 
CrPS. I wrote them off in all but the most severe 
cases, which were so dramatic they couldn’t be 
written off. 
I vividly remember the suffering those 
patients experienced, as well as my feelings of 
helplessness to offer any relief. CrPS is still not 
treatable, but now we know that vitamin C can 
help prevent it, or at least shorten its severity 
and duration. Granted, the symptoms can be 
mild, and most resolve spontaneously, but it can 
go on for months and it can be truly horrific in a 
small percent (1%–2%). 
Here is an instance in which an ounce of 
prevention is worth more than a pound of cure. 
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“my patients saw me, but i didn’t see them”
you can be a  
“realiTy checker”
If you are in full-time 
clinical  practice, a medical 
director of a practice, or 
otherwise directly involved 
in decision-making about 
adopting new practices, 
join our team of “reality 
checkers.”
Bernard  
Ewigman,  
MD, MSPH
Just email me at 
be.editor@gmail.com
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were enrolled in the study. The study 
was double-blinded, and allocation was 
adequately concealed. There was 100% 
follow-up of all patients. Of enrolled pa-
tients, 82.4% were women, and the aver-
age age of all subjects was 62.4 years.
Patients were randomized into 1 of 
4 groups: placebo, vitamin C 200 mg 
daily, vitamin C 500 mg daily, or vita-
min C 1500 mg daily for 50 days. Other 
fracture therapy was undertaken at the 
discretion of the treating physician. Pa-
tients were evaluated at 1 week, 4 or 5 
weeks (or cast removal), 6 or 7 weeks, 
12 weeks, and 26 weeks. After 1 year, pa-
tients were contacted by phone or mail 
to confirm their status using Veldman’s 
criteria (TABLE	1).8 
10%	of	the	placebo	group		
had	CRPS	after	1	year
One year after the fracture, 10% of pla-
cebo patients had a diagnosis of CRPS. 
Rates of CRPS were 4%, 2%, and 2% in 
the 200 mg, 500 mg, 1500 mg daily dos-
ing of vitamin C, respectively (TABLE	2).
There was no association between 
the development of CRPS and site of 
fracture, whether the fracture was dis-
placed or intraarticular, or whether 
surgical therapy was chosen (although 
90% of the fractures were treated with 
casting). Of note: all of the patients who 
developed CRPS were female; however, 
only 75 men were enrolled (18%). 
older patients were at increased risk, 
and patients with complaints about 
their cast were substantially more likely 
to have CRPS (number needed to harm 
[NNH]=2.6; odds ratio [OR]=5.73; 95% 
confidence interval [CI], 2.11–15.57). 
whaT’s new?
z		Effective	dose:	500	mg/d	
vitamin	C	for	50	days
Vitamin C at a dose of at least 500 mg/
day for 50 days reduced the rate of CRPS 
from 10% to 2% (number needed to 
treat [NNT]=13). This is the second study 
undertaken by the same investigators to 
demonstrate risk reduction.8 The previ-
ous study enrolled only 129 patients, but 
found an absolute risk reduction of 15% 
(NNT=7; P<.05) for patients taking 500 
mg of vitamin C. 
Patients who complained about their 
casts were at substantially higher risk of 
being diagnosed with CRPS (OR=10.0; 
95% CI, 2.9–33), suggesting that cast 
complaints may be a harbinger. 
The more recent study was also de-
signed to determine the effective dose 
for vitamin C. Doses of 200 mg daily re-
duced the risk, but the effect was not sta-
tistically significant. The effect size for the 
500 mg and 1500 mg doses, on the other 
hand, were essentially identical, and both 
statistically and clinically significant.1
caveaTs
Selection	bias?
The study enrolled less than 20% of po-
tentially eligible patients, raising the possi-
bility that only patients who might benefit 
from vitamin C prophylaxis were enrolled. 
However, almost two thirds of those eli-
gible were either never approached due 
to the emergency department being busy 
(43%), or refused randomization (14%) 
after they were informed in the consent 
process that there was evidence of benefit 
of vitamin C, based on the prior trial.8 
Therefore, selection bias seems an un-
likely explanation for the positive results. 
This is the second trial to show the same 
finding, which is reassuring.
no men had crPs in either group in 
this study, so there is no evidence to show 
Older patients  
are at greater risk 
for complex  
regional pain  
syndrome 
Veldman’s	criteria	for	diagnosis		
of	complex	regional	pain	syndrome,	type	1
must have 4 of the 5 symptoms below, at the affected hand or wrist,  
or during activity with that wrist:
• unexplained pain, not normal for typical treatment course
• Difference in skin color (compared to other wrist)
• Diffuse edema
• Difference in skin temperature (compared to other wrist)
• limited range of motion, not normal for typical treatment course
taBLE 1
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Vitamin C to prevent pain after fracture
whether or not this intervention works in 
men. We are unaware of any physiologic 
reason to suggest that vitamin C would 
have a differential effect in men. In the 
earlier study, only 1 man (in the placebo 
group) got CRPS, for an absolute risk dif-
ference of 0.08 (95% CI, –0.07 to 0.27).8 
What	are	the	diagnostic	criteria?	
There is no universal agreement on the 
diagnostic criteria for CRPS. This study 
used Veldman’s criteria (TABLE	1), which 
is the standard criteria used in The Neth-
erlands, and has the best inter-rater re-
liability of the current criteria.9 Criteria 
from the International Association of 
Studies in Pain are the most widely cited 
in the literature, but are not particularly 
specific or reproducible.9
challenges To imPlemenTaTion
Getting	vitamin	C	started
Recommending 500 mg of vitamin C 
daily for 7 weeks is a simple and low-cost 
intervention. Many of our patients will 
be treated acutely in emergency rooms or 
by orthopedic surgeons. If these clinicians 
do not initiate the vitamin C, it may be 
some time before the primary physician 
can begin this therapy. We don’t have any 
information on whether a delay in initia-
tion affects the efficacy of vitamin C. 
The evidence presented here is for 
Colles’s fractures, but CRPS definitely 
follows other fractures. We are unaware 
of any physiologic reason why vitamin C 
therapy would behave any differently for 
other fracture locations. 
It’s	a	mistake	to	think	CRPS	is	rare
Perhaps the greatest challenge to imple-
mentation is the perception that CRPS is 
a rare phenomenon or at least generally 
resolves spontaneously. 
The rate in the placebo group (1 in 
10 diagnosed at 1 year) and the rates re-
ported through systematic surveillance (1 
in 4 diagnosed at some point following 
Colles’s fracture) struck both us and the 
clinicians reviewing this study as high. 
We suspect symptoms are often 
missed or misdiagnosed. Even with reso-
lution,  the symptoms can be bothersome, 
and quite severe in a few cases (1% to 
2%). We think vitamin C 500 mg/day for 
7 weeks is well worth recommending. n
Purls methodology
This study was selected and evaluated using FPIN’s Priority updates 
from the research literature (Purl) Surveillance System method-
ology. The criteria and findings leading to the selection of this study 
as a Purl can be accessed at www.jfponline.com/purls. 
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The greatest  
challenge may be 
the perception  
that CRPS is rare  
or at least  
generally resolves  
spontaneously
Rates	of	complex	regional	pain	syndrome		
at	1	year:	10%	placebo,	2.4%	vitamin	C
TreaTmenT  PercenT  
grouP wiTh crPs rr (95% ci) arr nnT
Placebo 10%   
vitamin c
   all doses  2.4% 0.24 (0.10–0.60) 0.076 13 
combined
  200 mg 4% 0.41 (0.13–1.27) 0.06 17
  500 mg 2% 0.17 (0.04–0.77) 0.08 13
  1500 mg 2% 0.17 (0.04–0.75) 0.08 13
CrPS, complex regional pain syndrome; rr, relative risk; CI, confidence  
interval; arr, absolute risk reduction; NNT, number needed to treat.
Source: Zollinger et al, 2007.1
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